Related Experiment Videos
Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging
1Department of Radiology, Kaplan Comprehensive Cancer Center, New York University Medical Center, NY 10016, USA.
Radiology
|June 3, 1999
Summary
T2*-weighted echo-planar perfusion imaging effectively differentiates astrocytoma grades using cerebral blood volume (CBV) maps. This advanced MR imaging technique improves stereotactic biopsy targeting for better diagnostic accuracy.
Area of Science:
- Neuroimaging
- Oncology
- Radiology
Background:
- Astrocytomas require accurate grading for treatment planning.
- Conventional MRI may not provide sufficient detail for precise tumor characterization.
- Stereotactic biopsy is crucial for definitive histopathologic diagnosis.
Purpose of the Study:
- To assess the utility of T2*-weighted echo-planar perfusion imaging in grading astrocytomas.
- To determine the correlation between MR imaging-derived cerebral blood volume (CBV) and astrocytoma histopathologic grade.
- To evaluate the role of this perfusion technique in enhancing stereotactic biopsy targeting.
Main Methods:
- MR imaging was performed using a first-pass gadopentetate dimeglumine T2*-weighted echo-planar perfusion sequence in 29 patients.
- Relative cerebral blood volume (CBV) maps were generated from perfusion data.
- Maximum relative CBV values were correlated with histopathologic grades from stereotactic biopsies or resections.
Main Results:
- A statistically significant difference in maximum relative CBV was observed between high-grade and low-grade astrocytomas (P < .001).
- Mean relative CBV was 5.07 in high-grade astrocytomas versus 1.44 in low-grade astrocytomas.
- Perfusion imaging provided diagnostic information beyond conventional MR imaging.
Conclusions:
- Echo-planar perfusion imaging is valuable for preoperative assessment of astrocytoma tumor grade.
- This technique offers diagnostic insights not achievable with conventional MR imaging.
- Identifying areas of perfusion abnormality aids in precise stereotactic biopsy targeting.